DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced the pricing of an underwritten public offering of 47,619,048 shares of its common stock at a public offering price of $1.05 per share. The aggregate gross proceeds from this offering are expected to be $50 million, before deducting underwriting discounts and commissions and other offering expenses payable by Humacyte. The closing of the offering is expected to occur on or about June 12, 2026, subject to the satisfaction of customary closing conditions. In addition, Humacyte has granted the underwriters an option for a period of 30 days to purchase up to an additional 7,142,857 shares of Humacyte’s common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock are being sold by Humacyte.
From Taiwan to the World, Kavalan Marks a New Chapter in World Whisky HistoryTAIPEI, June 11, 2026 /PRNewswire/ -- Kavalan Whisky's best kept secret...
SYDNEY, June 11, 2026 /PRNewswire/ -- Insta360 announced Luna Ultra, its flagship gimbal camera co-engineered with Leica, built to combine professional imaging, 3-axis stabilization, and...
New York, NY, June 10, 2026 (GLOBE NEWSWIRE) -- byNordic Acquisition Corporation (“BYNO” or the “Company”), a special purpose acquisition company, announced today that the Company has timely deposited into the Company’s trust account (the “Trust Account”), an aggregate of $17,470, in order to extend the period of time the Company has to complete a business combination for an additional one (1) month period, from June 12, 2026 to July 12, 2026 (the “Extension”). The Extension is the eleventh of up to twelve (12) one-month extensions permitted under the August 8, 2025 amendment to the Company’s Amended and Restated Certificate of Incorporation that allows the Company’s board of directors, in its sole discretion and without another stockholder vote, to elect to extend the termination date by one additional month each time up until August 12, 2026, or the closing of the Company’s initial business combination.
THE WOODLANDS, Texas, June 10, 2026 /PRNewswire/ -- MIND Technology, Inc. (NASDAQ: MIND) ("MIND" or the "Company") today announced financial results for its fiscal...
AMT's demonstration in FANUC booth #1001 combines collaborative robotics and AI-enabled vision technology for mixed-load palletizing and depalletizing applications in warehouse and logistics environments.ORION,...
MONTRÉAL, June 10, 2026 /CNW/ - As the summer season approaches, ADM Aéroports de Montréal would like to remind travellers of some important tips to...
Certification Equips U.S. Government Agencies to Transform Customer ExperienceSAN FRANCISCO and NEW YORK, June 10, 2026 /PRNewswire/ -- Sierra, the leading AI-powered customer experience platform,...